Chemistry Wealth Management’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$399K Hold
1,261
– – 0.06% 150
2026
Q2
$377K Sell
1,261
-119
-9% -$33.1K 0.06% 151
2026
Q1
$376K Hold
1,380
– – 0.07% 147
2025
Q4
$397K Hold
1,380
– – 0.07% 130
2025
Q3
$358K Hold
1,380
– – 0.07% 146
2025
Q2
$343K Hold
1,380
– – 0.07% 135
2025
Q1
$365K Hold
1,380
– – 0.09% 121
2024
Q4
$350K Hold
1,380
– – 0.08% 122
2024
Q3
$389K Sell
1,380
-3
-0.2% -$833 0.09% 115
2024
Q2
$368K Hold
1,383
– – 0.1% 114
2024
Q1
$374K Hold
1,383
– – 0.1% 114
2023
Q4
$347K Sell
1,383
-24
-2% -$5.68K 0.1% 116
2023
Q3
$331K Hold
1,407
– – 0.11% 118
2023
Q2
$344K Sell
1,407
-28
-2% -$6.81K 0.11% 114
2023
Q1
$342K Buy
1,435
+17
+1% +$4.09K 0.12% 113
2022
Q4
$352K Hold
1,418
– – 0.14% 101
2022
Q3
$317K Hold
1,418
– – 0.13% 111
2022
Q2
$334K Sell
1,418
-109
-7% -$26.3K 0.13% 113
2022
Q1
$388K Buy
+1,527
New +$377K 0.13% 103

Other funds holding VHT

Chemistry Wealth Management's VHT Position: Q3 2026 in Review

Chemistry Wealth Management held its Vanguard Health Care ETF (VHT) position steady in Q3 2026 at 1,261 shares worth $399K. The position accounts for 0.06% of the portfolio, ranked #150.

Chemistry Wealth Management first reported a position in VHT in Q1 2022 and has held it in 19 quarters since. 1,030 funds tracked by Wall St. Rank hold VHT as of Q3 2026.

  • Chemistry Wealth Management held 1,261 shares of Vanguard Health Care ETF worth $399K as of Q3 2026.
  • Chemistry Wealth Management left its Vanguard Health Care ETF share count unchanged in Q3 2026.
  • Vanguard Health Care ETF made up 0.06% of Chemistry Wealth Management's portfolio in Q3 2026, its #150 holding.
  • Chemistry Wealth Management first reported a position in Vanguard Health Care ETF in Q1 2022 and has held it in 19 quarters since.
  • 1,030 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q3 2026.

Based on Chemistry Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.